A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation
Abstract Background Essential thrombocythemia (ET) is a rare cause of stroke. The V617F mutation in the Janus kinase 2 (JAK2) gene is one of the most typical mutations in ET and has been shown to be a risk factor for stroke, especially in younger people. However, to date, there have been few reports...
Main Authors: | Ran Yan, Donghua Mi, Xin Qiu, Zixiao Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-022-02964-z |
Similar Items
-
Essential Thrombocythemia Following Immune Thrombocytopenia With JAK2 V617F Mutation: A Case Report
by: Mehrdad Payandeh, et al.
Published: (2021-11-01) -
Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
by: İpek Yonal, et al.
Published: (2016-05-01) -
Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients
by: Zehra Narlı Özdemir, et al.
Published: (2024-03-01) -
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
by: Federico Lussana, et al.
Published: (2017-02-01) -
A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia
by: Zhuanghui Hao, et al.
Published: (2024-01-01)